Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Asia
Pharma
Merck partner Kelun touts ph. 3 win for ADC in first-line NSCLC
A phase 3 trial of a combo of sac-TMT and Keytruda met its primary endpoint in first-line PD-L1-positive NSCLC, Kelun said.
Angus Liu
Nov 24, 2025 10:56am
Supply chain ties, Bayer biotech incubator—Fierce Pharma Asia
Nov 21, 2025 8:00am
Pfizer, Akeso, Lilly and more—Fierce Pharma Asia
Nov 14, 2025 8:50am
Akeso details ivonescimab's 1st overall survival win
Nov 7, 2025 11:30am
Lilly-XtalPi, Celltrion, Illumina in China—Fierce Pharma Asia
Nov 7, 2025 9:41am
AstraZeneca adds $136M investment to Chinese inhalants facility
Nov 5, 2025 11:14am
